AngioDynamics, Inc. - Common Stock (ANGO)

Competitors to AngioDynamics, Inc. - Common Stock (ANGO)

Abbott Laboratories 

Abbott competes with AngioDynamics mainly through its vascular and cardiovascular devices. Abbott's comprehensive approach, including drug-eluting stents and diagnostic imaging products, allows it to address a wider scope of patient needs compared to AngioDynamics, which specializes in targeted treatments. Abbott's extensive market presence, coupled with its innovations and global distribution, grants it a competitive advantage in attracting diverse healthcare facilities and practitioners.

BD (Becton, Dickinson and Company) 

BD and AngioDynamics compete primarily in the vascular access segment and medical devices market. BD has a much larger market share, extensive resources, and a broader product line, including a significant presence in safety-engineered devices. While AngioDynamics focuses on niche solutions like minimally invasive procedures and innovative technologies such as their Auryon laser system, BD leverages its strong distribution network and established brand presence, providing it with a competitive advantage.

Boston Scientific Corporation 

Boston Scientific and AngioDynamics compete in the catheter and vascular access markets. Boston Scientific has a robust portfolio, particularly in peripheral interventions and electrophysiology, which allows it to cater to a broader range of medical needs. While AngioDynamics highlights its unique, less-invasive technologies like the BioFlo catheter, Boston Scientific's established reputation in larger therapeutic areas and significant investment in clinical trials provides it with a competitive advantage within the market.

Medtronic plc 

Medtronic competes with AngioDynamics in the field of vascular therapies, particularly through its advanced catheter systems and minimally invasive surgical technologies. Medtronic's extensive R&D capabilities and diversified product portfolio, including their market-leading stents and balloons, give them an edge over AngioDynamics. While AngioDynamics is recognized for specialized products focusing on cancer and peripheral vascular disease, Medtronic's size and reach afford it significant competitive advantages in terms of marketing and product development.

Teleflex Incorporated 

Teleflex and AngioDynamics overlap in several sectors, particularly in the vascular access and surgical support devices market. Teleflex’s comprehensive range of products and significant investment in product development positions it well against AngioDynamics. Although AngioDynamics has a strong focus on innovative solutions for targeted therapies, Teleflex's extensive clinical resources and broader product offerings often make it a more appealing choice for hospitals and outpatient centers, giving them a competitive foothold.